Pharmer.org

(Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.

(Reuters Health) - People who have a lot of trouble hearing may be almost twice as likely to experience an accidental injury as individuals with excellent or good hearing, a U.S. study suggests.

(Reuters Health) - Pregnant women who drink lots of coffee and other caffeinated beverages may be more likely to have kids who are overweight than mothers who limit caffeine during pregnancy, a Norwegian study suggests.

(Reuters Health) - Elderly people who are prescribed opioids may be at higher risk for injuries from falls, some of which may be fatal, a Canadian analysis of trauma cases suggests.

LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it.

(Reuters) - The U.S. Food and Drug Administration on Tuesday said it launched a crackdown on the sale of e-cigarettes and tobacco products to minors, particularly those developed by Juul Labs Inc.

Armenia's opposition lawmaker Nikol Pashinyan led mass anti-government protests that culminated in the resignation of newly appointed Prime Minister Serzh Sarkisian and has declared he is ready to lead the country. A fortnight ago, few in Armenia would have believed that the 42-year-old could bring tens of thousands of people out onto the streets of Yerevan and other cities, eventually forcing the veteran leader to resign. Before these protests, Pashinyan was mostly associated with the tragic events following the 2008 presidential vote that first brought Sarkisian to power, when 10 people died in clashes between police and supporters of the defeated opposition candidate.

One of the prosecutors who brought the case against Scooter Libby says President Trump's pardon of the ex-top aide to former Vice President Dick Cheney sends a not-so-subtle message to potential witnesses in special counsel Robert Mueller’s Russia investigation.

(Reuters) - An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster.

Police haven't commented on his motive

GENEVA (Reuters) - Malaria is spreading rapidly in crisis-hit Venezuela, with more than an estimated 406,000 cases in 2017, up roughly 69 percent from a year before, the largest increase worldwide, the World Health Organization (WHO) said on Tuesday.

People who practice polyamory understand the world's curiosity: Loving more

The first of 10 victims was identified as Anne Marie D'Amico, who worked at an investment management firm.

LONDON (Reuters) - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca clinical study.

### TOP STORIES

BRUSSELS (Reuters) - Ireland gained EU approval on Tuesday for a tax on sugary drinks after regulators said the levy would help the country tackle health and obesity issues.

Someone light a match.

LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.

LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they are on a special pregnancy prevention program.

(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.